ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers
SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project
1 other identifier
observational
1,000
1 country
1
Brief Summary
The novel coronavirus (SARS-CoV-2) has spread all around the world and testing has posed a challenge globally. Health care providers are highly exposed and are an important group to test. On top of these concerns, health care workers are also stressed by the needs on responders in the COVID-19 crisis. The investigators will look at different ways to measure how common COVID-19 is among health care workers, how common is the presence of antibodies by serological tests (also known as serostatus). The investigators will describe health worker mental and emotional well-being and their coping strategies in their institutional settings. Lastly, the investigators will describe how knowing serostatus can affect individuals' mental and emotional well-being and how to cope in the midst of the COVID-19 response. This will help to how to better test and help healthcare workers in the COVID-19 pandemic and prepare for possible future outbreaks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 18, 2020
CompletedFirst Submitted
Initial submission to the registry
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
April 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
April 8, 2026
April 1, 2026
6.8 years
April 28, 2020
April 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion seropositive
Percentage of health care workers with positive serological markers to describe patterns in exposure, re-infection, clinical symptom, serological responses among health care workers based on their baseline serological status over a one year period.
Up to 12 months after collection visit
Study Arms (4)
Prior Positive polymerase chain reaction (PCR) and Recovered
Prior Positive PCR result, fully recovered, back at work and symptom free for greater than or equal than 14 days.
Never tested, history of COVID-19 Symptoms and Recovered
Never tested and history of COVID-19 symptoms and symptom-free for more than 14 days
Never tested and current COVID-19 Symptoms
Never tested and current COVID-19 Symptoms (e.g. referred by a provider or clinic)
Never tested and asymptomatic
Never tested and asymptomatic for COVID-19 symptoms, including asymptomatic health care worker
Interventions
Quantitate Serology enzyme-linked immunosorbent assay (ELISA) for COVID-19
The purpose of this survey is to assess how healthcare workers are experiencing and coping with the COVID-19 crisis.
Eligibility Criteria
Employee of NewYork-Presbyterian Hospital and its affiliates
You may qualify if:
- years of age or older
- NewYork-Presbyterian (NYP) healthcare personnel employee or affiliate
- Understands and reads English
You may not qualify if:
- Younger than 18 years of age
- Mentally and/or physically unable to complete study requirements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Magdalena Sobieszczyk, MD, MPH
Columbia University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Year
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2020
First Posted
April 29, 2020
Study Start
April 18, 2020
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
April 8, 2026
Record last verified: 2026-04